פרימקור זריקות

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

MILRINONE

MAH:

SANOFI ISRAEL LTD

ATC_code:

C01CE02

pharmaceutical_form:

תמיסה להזרקה

composition:

MILRINONE 1 MG/ML

administration_route:

תוך-ורידי

prescription_type:

מרשם נדרש

manufactured_by:

DELPHARM DIJON, FRANCE

therapeutic_group:

MILRINONE

therapeutic_area:

MILRINONE

therapeutic_indication:

For the treatment of refractory heart failure immediately (up to 72 hours) following cardiac surgery. For the short term ( up to 48 hours) intravenous therapy of severe refractory congestive heart failure.

authorization_date:

2022-11-30